News & Analysis The Ledger Pricing audits, regulatory briefings, and provider alerts. The paper trail on prescribed peptide therapy. Regulatory BriefingMedicare Now Covers GLP-1s at $50/MonthThe GLP-1 Bridge went live July 1, 2026. Who qualifies.Price WatchThe Compounded Semaglutide Price WarBrand collapsed to $149–$349. Who's actually winning.Regulatory BriefingWhat the FDA PCAC Meeting Means for YouSeven peptides before the committee July 23–24.Regulatory BriefingBPC-157's Legal PathThe most-searched repair peptide meets the regulator.Consumer Protection7 Red Flags When Choosing a ProviderThe patterns that separate good from bad.The Real CostThe Hidden Fees in Telehealth PeptidesWhere the advertised price stops matching the invoice.GuideSwitching From Research to PrescribedThe practical transition, including the awkward parts.